Vitamin K: The Overlooked Regulator of Bone, Vascular, and Coagulation Health
- David Stephen Klein, MD FACA FACPM
- 3 days ago
- 5 min read
Introduction
Vitamin K is commonly described as the “clotting vitamin,” but this definition understates its clinical importance. In reality, vitamin K functions as a master regulator of calcium physiology, directing calcium into bone while preventing its deposition in soft tissues such as arteries.
From a clinical standpoint, vitamin K bridges several disciplines—hematology, endocrinology, and cardiovascular medicine—and plays a meaningful role in conditions ranging from osteoporosis to vascular calcification.
What Is Vitamin K?
Vitamin K is a fat-soluble vitamin required for activation of a group of proteins through γ-carboxylation, a biochemical process essential for their function.
These include:
Clotting factors II, VII, IX, X
Protein C and Protein S (natural anticoagulants)
Osteocalcin (bone mineralization)
Matrix Gla protein (inhibits vascular calcification)
Without adequate vitamin K, these proteins remain inactive, leading to impaired coagulation and dysregulated calcium deposition.
Vitamin K Forms: K1, K2, and K3
Vitamin K1 (Phylloquinone)
Found in leafy green vegetables
Primarily supports hepatic clotting factor synthesis
Short half-life
Essential for preventing bleeding disorders
Vitamin K2 (Menaquinones)
A family of compounds (MK-4 through MK-9) with distinct physiologic roles:
MK-4
Found in animal products (egg yolks, butter, liver)
Short half-life
Rapid tissue uptake
MK-7
Found in fermented foods (e.g., natto)
Long half-life (~48–72 hours)
Stable circulating levels
Strong evidence for bone and vascular support
Other MK forms (MK-8, MK-9)
Produced by gut microbiota
Less well characterized clinically
Vitamin K3 (Menadione) — A Critical Distinction
Vitamin K3 is a synthetic compound that differs fundamentally from K1 and K2.
Water-soluble precursor of vitamin K
Historically used due to low cost and stability
No longer used in human supplementation
Why K3 Is Not Used Clinically
Unlike K1 and K2, vitamin K3 has been associated with:
Oxidative cellular injury (reactive oxygen species generation)
Hemolytic anemia, particularly in susceptible individuals (e.g., G6PD deficiency)
Liver toxicity
Neonatal complications, including hyperbilirubinemia
As a result, vitamin K3 has been abandoned in human medicine and remains limited to veterinary applications.
Clinical takeaway:Vitamin K3 should be avoided in all human supplementation contexts.
K1 vs K2: Functional Differences
Feature | Vitamin K1 | Vitamin K2 (MK-7) |
Primary role | Clotting | Bone & vascular health |
Half-life | Short | Long |
Distribution | Liver | Bone, arteries |
Clinical use | Essential | Increasingly emphasized |
Simplified clinical perspective:
K1 prevents bleeding
K2 helps prevent inappropriate calcium deposition
Vitamin K and Bone Health
Vitamin K is essential for activation of osteocalcin, a protein that binds calcium within bone.
Clinical implications include:
Improved bone mineralization
Potential reduction in fracture risk
Synergistic effect with vitamin D
Vitamin K2, particularly MK-7, has demonstrated favorable effects on bone density in multiple studies.
Vitamin K and Cardiovascular Health
Matrix Gla protein (MGP), a vitamin K–dependent protein, plays a central role in preventing vascular calcification.
Low vitamin K status has been associated with:
Increased coronary artery calcification
Arterial stiffness
Higher cardiovascular mortality
This highlights a key concept: Calcium balance depends not only on intake, but on proper biologic direction.
Recommended Dosages
Vitamin K1
Men: ~120 mcg/day
Women: ~90 mcg/day
Vitamin K2 (MK-7)
Common supplemental range: 90–200 mcg daily (average young adult through middle age)
Vitamin K2 (MK-4)
Higher doses used in some protocols (e.g., 15 mg/day in divided dosing) (average young adult through middle age)
Safety Profile
Vitamin K1 and K2 are among the safest fat-soluble vitamins:
No established toxicity at standard doses
Minimal risk of accumulation
Well tolerated
Exception: Vitamin K3
Associated with clinically significant toxicity
Not recommended under any circumstance for human use
Medication Interactions and Clinical Cautions
1. Warfarin (Coumadin)
Vitamin K directly antagonizes warfarin’s mechanism.
Increased vitamin K → reduced anticoagulation
Decreased vitamin K → increased bleeding risk
Clinical principle :Consistency of intake is essential—not elimination.
2. Direct Oral Anticoagulants (DOACs)
(e.g., apixaban, rivaroxaban)
No direct interaction with vitamin K
Supplementation generally acceptable
3. Antibiotics
Broad-spectrum antibiotics may:
Reduce gut-derived vitamin K production
Increase deficiency risk
4. Fat Malabsorption Syndromes
Seen in:
Pancreatic insufficiency
Celiac disease
Bariatric surgery
These patients may require supplementation.
5. Liver Disease
Reduced clotting factor synthesis
Increased sensitivity to vitamin K deficiency
Who Should Consider Supplementation?
Vitamin K—particularly K2—may be beneficial in:
Osteopenia or osteoporosis
Patients with cardiovascular risk or calcification
Individuals on long-term vitamin D therapy
Postmenopausal women
Those with low dietary intake
Dietary Sources
Vitamin K1
Kale
Spinach
Collard greens
Broccoli
Vitamin K2
Natto (highest source)
Egg yolks
Cheese
Liver
Practical Clinical Takeaways
Vitamin K is a regulator of calcium distribution, not just clotting
K1 supports coagulation; K2 supports bone and vascular health
K3 (menadione) is obsolete and potentially harmful
Vitamin K works synergistically with vitamin D and magnesium
Medication interactions—especially with warfarin—require careful management
Bottom Line
Vitamin K is essential not only for clotting but for directing calcium into bone and away from arteries. While vitamin K1 supports coagulation, vitamin K2—particularly MK-7—offers meaningful benefits for bone density and cardiovascular health. Vitamin K3, in contrast, is a synthetic and potentially toxic compound with no role in modern human supplementation. When used appropriately, vitamin K is a safe and powerful component of a longevity-focused medical strategy.
Call to Action
If you are concerned about bone health, cardiovascular risk, or optimizing your nutritional strategy, we can help guide you with individualized testing and targeted supplementation.
👉 Become a patient at Stages of Life Medical Institutehttps://www.stagesoflifemedicalinstitute.com
References
Shearer MJ, Newman P. Vitamin K metabolism and function. Thromb Haemost. 2008.
Booth SL. Roles for vitamin K beyond coagulation. Annu Rev Nutr. 2009.
Beulens JWJ, et al. The role of menaquinones in human health. Br J Nutr. 2013.
Knapen MHJ, et al. Vitamin K2 supplementation improves arterial stiffness. Thromb Haemost. 2015. https://pubmed.ncbi.nlm.nih.gov/25694037/
Schwalfenberg GK. Vitamins K1 and K2: emerging group. J Nutr Metab. 2017.
Fusaro M, et al. Vitamin K and bone. Clin Cases Miner Bone Metab. 2017.
Vermeer C. Vitamin K: the effect on health beyond coagulation. Eur J Clin Nutr. 2012.
Rishavy MA, Berkner KL. Vitamin K oxygenation and toxicity mechanisms. Biochemistry. 2012.
Sato Y, et al. Vitamin K2 and fracture prevention. J Bone Miner Metab. 2005.
Olson RE. The function and metabolism of vitamin K. Annu Rev Nutr. 1984.
The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.
1917 Boothe Circle, Suite 171
Longwood, Florida 32750
Tel: 407-679-3337
Fax: 407-678-7246
.webp)